Galectin Therapeutics Inc. (GALT) Earnings
Galectin Therapeutics Inc. is expected to report next earnings on November 16, 2026 (in NaN days), with a consensus EPS estimate of $-0.05. GALT has beaten EPS estimates in 6 of its last 12 reported quarters (average surprise -21.8% over the last four).
Next earnings
Nov 16, 2026in NaN days
EPS est $-0.05 · Revenue est —
Track record
Beat EPS in 6 of 12 quarters
Avg surprise -21.8% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 14, 2026 | $-0.09 | $-0.14 | -55.6% | — | — |
| May 15, 2026 | $-0.06 | $-0.08 | -33.3% | — | — |
| Mar 31, 2026 | $-0.10 | $-0.08 | +20.0% | — | — |
| Nov 14, 2025 | $-0.11 | $-0.13 | -18.2% | — | — |
| Aug 14, 2025 | $-0.16 | $-0.12 | +25.0% | — | — |
| May 15, 2025 | $-0.20 | $-0.15 | +25.0% | — | — |
| Mar 31, 2025 | $-0.16 | $-0.19 | -18.8% | $36000 | — |
| Nov 14, 2024 | $-0.20 | $-0.18 | +10.0% | — | — |
| May 15, 2024 | $-0.16 | $-0.19 | -18.8% | — | — |
| Mar 29, 2024 | $-0.16 | $-0.16 | +0.0% | $80000 | — |
| Aug 14, 2023 | $-0.21 | $-0.15 | +28.6% | — | — |
| May 15, 2023 | $-0.21 | $-0.19 | +9.5% | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.